
US FDA approves Regeneron's blood cancer therapy
The Hindu
Regeneron Pharmaceuticals gains FDA approval for Lynozyfic drug targeting multiple myeloma, with launch details and executive comments included.
More Related News

After being repeatedly disrupted for three consecutive days over issues ranging from the Governor’s address and alleged disrespect to the national anthem to demands for the resignation of the Excise Minister, among others, normalcy finally returned to the Legislative Council on Friday, with proceedings commencing.












